It is indicated for the treatment of patients with Covid-19 who are not hospitalized, but are likely to progress to a severe level due to age or other health problems.
Bamlanivimab is a special monoclonal antibody against the mutant protein of the virus SARS-CoV-2 when it is possible to suppress viral binding and viral penetration into human cells. A similar treatment developed by Regeneron Pharmaceuticals Inc was also used by President Trump when he contracted Covid-19 in early October.
In an emailed statement, the White House praised the US Food and Drug Administration’s decision as a milestone. The drug may be prescribed to anyone over 65 years of age newly diagnosed with mild to moderate Covid-19 and for patients 12 years of age and older with an underlying medical condition that puts them at risk. muscle is seriously ill. However, the drug is not indicated for hospitalized patients as well as those requiring mechanical ventilation, as it may worsen the clinical outcome.